| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $154.3M | +4.5% | +19.5% |
| Cost of Revenue | $49.3M | +6.2% | -23.5% |
| Gross Profit | $105.1M | +3.8% | +62.3% |
| R&D Expense | $30.6M | -9.7% | -63.1% |
| SG&A Expense | $28.4M | -3.1% | -61.8% |
| Operating Income | -$17.5M | +45.8% | +93.2% |
| Pre-tax Income | -$11.6M | +52.0% | +95.3% |
| Income Tax | -$119K | -119.3% | -271.9% |
| Net Income | -$8.8M | +52.0% | +94.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $653.9M | +0.3% | +32.0% |
| Accounts Receivable | $151.7M | +37.7% | +33.6% |
| Current Assets | $863.2M | +5.0% | +30.1% |
| Total Assets | $949.4M | +4.3% | +26.6% |
| Current Liabilities | $364.7M | +6.3% | +34.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $70.9M | — | — |
| Capital Expenditures | $924K | — | — |
| Investing Cash Flow | -$4.6M | — | — |
| Financing Cash Flow | $43.2M | — | — |
| Free Cash Flow | $70.0M | — | — |
| $386.6M |
| +6.2% |
| +32.4% |
| Stockholders' Equity | $472.1M | +3.0% | +3.0% |